Table 1.

Intervention scenarios for India and South Africa⁸

	Activities	Programme targets	Mechanism of action for health effects
India
Improving treatment quality	Improved private-sector quality through provider training, supervision, regulation, and subsidies; retention of patients in care by incentives, nutritional support, and link to social welfare programmes	Initial decrease in patients stopping treatment from 10% to 5% by 2015 for DS-TB and from 11% to 5% by 2020 for MDR-TB; treatment success measured as increases in adherence from 75% to 85% and from 48% to 67%, respectively	Improved retention of patients receiving care leading to increased cure rates
South Africa
Expanding access to care	Outreach clinics to underserved areas and symptom screening in primary care	Decrease population without access to care from 5% to zero by 2022	Reduced duration of infectiousness and mortality risks by improved case detection
Improving treatment quality	Mobile health care, follow-up of patients in the community, counselling on adherence to treatment, and improved MDR-TB staffing	Initial decreases in patients stopping treatment from 17% to 5% by 2021 for DS-TB and from 30% to 15% by 2021 for MDR-TB; treatment success measured as increases in adherence from 76% to 85% and from 52% to 67%, respectively	Improved retention of patients receiving care leading to increased cure rates

DS-TB=drug-sensitive tuberculosis. MDR-TB=multidrug-resistant tuberculosis.